“Test and not treat” for onchocerciasis control in a Loa loa endemic area

BACKGROUND: Implementation of ivermectin-based community treatment for onchocerciasis or lymphatic filariasis elimination has been delayed in Central Africa because of severe adverse events (SAEs), including death, in people with high levels of circulating Loa loa microfilariae (mf). LoaScope, a rap...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamgno, Joseph, Pion, Sébastien D., Chesnais, Cédric B., Bakalar, Matthew H., D'Ambrosio, Michael V., Mackenzie, Charles D., Nana-Djeunga, Hugues C., Gounoue-Kamkumo, Raceline, Njitchouang, Guy-Roger, Nwane, Philippe, Tchatchueng-Mbouga, Jules B., Wanji, Samuel, Stolk, Wilma A., Fletcher, Daniel A., Klion, Amy D., Nutman, Thomas B., Boussinesq, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629452/
https://www.ncbi.nlm.nih.gov/pubmed/29116890
http://dx.doi.org/10.1056/NEJMoa1705026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629452/
https://www.ncbi.nlm.nih.gov/pubmed/29116890
http://dx.doi.org/10.1056/NEJMoa1705026

Ejemplares similares